American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (989)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1261)
  3. Research Letter (46)
  4. Review (43)
  5. Editorial (35)
  6. Guidelines (14)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4003)
  2. Hematologic Malignancies, Division of (3806)
  3. Center for Hematologic Malignancies (3683)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1345)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (349)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (68)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5175)
  2. Blood Advances (334)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5559)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease
    Meeting Abstract

    Smith, M.; Ghosh, A.; James, S.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Schietinger, A.; Sadelain, M. W.; van den Brink, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Enasidenib (AG-221), a potent oral inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) enzyme, induces hematologic responses in patients with myelodysplastic syndromes (MDS)
    Meeting Abstract

    Stein, E. M.; Fathi, A. T.; DiNardo, C. D.; Pollyea, D. A.; Swords, R. T.; Roboz, G. J.; Collins, R.; Sekeres, M. A.; Stone, R. M.; Attar, E. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) harbors frequent splicesosome mutations that cause aberrant RNA splicing affecting genes critical in pDC differentiation and function
    Meeting Abstract

    Togami, K.; Madan, V.; Li, J.; Villani, A. C.; Sarkizova, S.; Ghandi, M.; Buczkowski, K.; Li, Y.; Biichle, S.; Angelot-Delettre, F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • No association of EBV or immunosuppression status with outcomes in US patients with diffuse large B-cell lymphoma treated in the immunochemotherapy era
    Meeting Abstract

    Tracy, S. I.; Habermann, T. M.; Feldman, A. L.; Maurer, M. J.; Dogan, A.; Perepu, U. S.; Syrbu, S.; Ansell, S.; Thompson, C. A.; Weiner, G. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Targeting cellular metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-Kb inhibitor
    Meeting Abstract

    Vaisitti, T.; Gaudino, F.; Ouk, S.; Serra, S.; Zakrzewski, J. L.; Bhavsar, E. B.; Allan, J. N.; Liou, H. C.; Furman, R. R.; Deaglio, S.
    Blood (2016)

    Fulltext@MSK | Save
  • Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries
    Meeting Abstract

    Velardi, E.; Tsai, J. J. Y.; Argyropoulos, K. V.; Jae-Hung, S.; Lieberman, S.; Kreines, F.; Shono, Y.; Young, L.; Wertheimer, T.; Jenq, R. R.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • AMC-053: Pilot study of an oncolytic viral strategy using bortezomib with ICE +/- rituximab for relapsed/refractory HIV+ lymphomas
    Meeting Abstract

    Reid, E. G.; Looney, D.; Maldarelli, F.; Noy, A.; Henry, D. H.; Aboulafia, D. M.; Ramos, J. C.; Sparano, J.; Ambinder, R. F.; Lee, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Leukemia-specific delivery of mutant NOTCH1 targeted therapy
    Meeting Abstract

    Roti, G.; Qi, J.; Kitara, S.; Varca, A. C.; Sanchez-Martin, M.; Kung, A. L.; Ferrando, A. A.; Bradner, J. E.; Stegmaier, K.
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I trial of Janus kinase (JAK) inhibition with INCB039110 in acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Schroeder, M. A.; Khoury, H. J.; Jagasia, M.; Ali, H.; Schiller, G. J.; Arbushites, M.; Delaite, P.; Yan, Y.; Rhein, K.; Perales, M. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save